In a statement, Ro said, "We are working to ensure patients have access to the most effective medications available and will continue to follow all applicable FDA rules and guidelines." The supply update "starts the clock on having unfettered market access to the patented drug" for companies like Hims & Hers and the broader compounding GLP-1 space, analysts at Leerink Partners wrote in a note to clients Friday morning
Preman, P., Alfonso-Triguero, M., Alberdi, E., Verkhratsky, A
This is how euglycemic DKA can develop ketones rise without dramatic hyperglycemia
These are the same brain (GIP) pathways that are connected to nicotine addiction
PlexusDx recommends discussing persistent fatigue with your healthcare provider to rule out underlying conditions before assuming the medication is responsible
The frequency and severity of diarrhea typically correlate with dose escalation